Skip to main content

Table 4 Logistic regression model to predict the presence of acute ischemic stroke in relation to prevalence of KIR haplotypes

From: HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute ischemic stroke

Variable

Beta

Exp(B)

95% confidence interval for Exp(B)

p value

HLA-A-Bw4

0.16

1.18

0.42–3.26

0.745

HLA-A aplotype

0.17

1.19

0.48–2.9

0.702

HLA-C1

0.09

1.09

0.35–3.4

0.874

HLA-C2

0.55

1.73

0.53–5.69

0.361

HLA-B-Bw4T

0.30

1.35

0.44–4.11

0.593

HLA-B-Bw4I

− 3.64

0.02

0.008–0.08

< 0.0001

2DL2-HLA-C1

− 1.90

0.149

0.041–0.55

0.004

2DL3-HLA-C1

0.32

1.37

0.50–3.75

0.529

2DS2-HLA-C1

0.68

1.97

0.67–5.83

0.216

2DS2-HLA-C2

2.68

14.68

2.33–92.4

0.004

2DL2-HLA-C2

0.13

1.14

0.34–3.84

0.825

2DS1-HLA-C2

− 0.27

0.75

0.21–2.64

0.667

2DL1-HLA-C1

0.37

1.45

0.34–6.07

0.607

2DL2-HLA-C1_A

1.84

6.33

1.46–27.47

0.014

2DL1-HLA-C2

0.03

1.03

0.30–3.59

0.953

  1. KIR killer cell immunoglobulin-like receptor, HLA human leukocyte antigen